CD79A and dengue disease: The study of Nascimento et al. (2018) found out that anti-dengue NS1 IgG and IgG3 have the potential to be developed as biomarkers for long term DENV infection instead of the common biomarkers used to detect acute infection such as IgA and IgM antibodies (Balmaseda et al., 2003).